explore -WSS

explore

author：entertainment 2025-09-30 18:47:58 - browse：5

The Novartis booth at ESMO in Madrid. — The Novartis booth at ESMO 2023 in Madrid. Andrew Joseph/STAT

MADRID — Results presented Monday could expand the use of a Novartis therapy for metastatic prostate cancer, moving it from a treatment used after chemotherapy to one with demonstrated benefits beforehand as well.

The Phase 3 data, highlighted in a prime session here at the annual meeting of the European Society for Medical Oncology, also amount to another win for cancer therapies designed to deliver radiation directly to tumor cells. It’s a field that Novartis has poured investments into, and that is attracting interest from other pharma companies.

The trial, called PSMAfore, enrolled patients with a type of metastatic prostate cancer whose disease had started to progress after taking a drug known as an androgen receptor pathway inhibitor, or ARPI. Patients were randomized to either receive a different ARPI or Novartis’ therapy, Pluvicto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Medical leaders decry Supreme Court decision on affirmative action

entertainment

hotspot

WSS

The cancer drug shortage isn’t new — and neither are the solutions

Heart attack and stroke risk calculators need revising

Heat waves linked to early deliveries, preterm births in new study

What will save rural psychiatry services? Higher Medicaid payments

Biohaven protein

Insmed lung disease drug hits target in key Phase 3 trial

leisure time

explore

explore

Alkermes shareholders re

Virginia high school admissions case could be legal follow

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Peter Hotez and the public health issue of online harassment

How one medical school became remarkably diverse

iTeos Therapeutics debuts first data on TIGIT

Heart attack and stroke risk calculators need revising

Scientists successfully use ultrasound imaging to map brain activity

Medical records are filled with copy

Stigma and the return of syphilis

entertainment

New air purifier tech could be key to improving indoor air quality

What will save rural psychiatry services? Higher Medicaid payments

Moonlake's readout produced a cash windfall. Risks remain

Childbirth

Duchenne breakthrough therapy leaves behind pioneering families

Guidelines to prevent youth baseball injuries need more muscle

entertainment

entertainment

hotspot

focus